Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Embecta Corp. (EMBC) Guidance & Earnings Results

On 2026-08-07 Embecta Corp. raised guidance: "FY2026 revenue guidance reaffirmed; adjusted operating margin and adjusted EPS guidance…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

EMBCEmbecta Corp.Follow EMBC — free
Medical Instruments & Supplies · Healthcare
—
Price chart with a free account
Market cap
380.2M
P/E TTM
4.6
Dividend yield
6.9%
52-week
—
Next earnings
23 Nov, in 30 days

What management guided

each earnings 8-K · figures checked against the filing text
ReleaseDirectionWhat they said
7 Aug 26RaisedFY2026 revenue guidance reaffirmed; adjusted operating margin and adjusted EPS guidance raised · full year
5 May 26LoweredLowered fiscal year 2026 financial guidance · full year
5 Feb 26ReaffirmedMaintaining previously provided guidance for key financial reporting metrics · full year
25 Nov 25LoweredProvides initial fiscal year 2026 financial guidance · full year
8 Aug 25RaisedFiscal 2025 outlook tightened and raised for key financial metrics · full year

Embecta Corp. — questions

What guidance did Embecta Corp. give?
On 2026-08-07: "FY2026 revenue guidance reaffirmed; adjusted operating margin and adjusted EPS guidance raised"
When does Embecta Corp. report earnings?
Embecta Corp.'s next earnings report is expected on 2026-11-23.

Every figure on this page comes from Embecta Corp.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.